ArticleAmerican journal of epidemiology2022
Invited Commentary: Drug Checking for Novel Insights Into the Unregulated Drug Supply.
Article in American journal of epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Trends in synthetic cathinone detection in seized drug samples submitted to the U.S. DEA's National Forensic Laboratory Information System, 2010-2024.Journal of analytical toxicology · 2026Article
- Drug sellers' use of a drug checking service amid the overdose crisis in British Columbia, Canada.Addiction (Abingdon, England) · 2026Article
- Neural Network-Based Detection of Adulterants in Opioid Samples Using IR Absorption Spectroscopy.Drug testing and analysis · 2026Article
- Temporal and regional associations between fentanyl concentrations in the unregulated drug supply and drug-related mortality in British Columbia, Canada.The International journal on drug policy · 2026Article
- "No judgment, no preaching": approaches to harm reduction service provision for people who use drugs in North Carolina.Harm reduction journal · 2026Article
- How population-level drug supply data are integrated into health outcomes research: a scoping review.Epidemiologic reviews · 2026Article
- Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: a serial cross-sectional analysis.Lancet regional health. Americas · 2024Article
- Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.Harm reduction journal · 2024Article
- "It gets you high as a kite but not unsick": Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island.The International journal on drug policy · 2024Article
- A scoping review of law enforcement drug seizures and overdose mortality in the United States.The International journal on drug policy · 2024Article
- Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.Harm reduction journal · 2024Article
- Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA.Harm reduction journal · 2024Review
- Xylazine in Overdose Deaths and Forensic Drug Reports in US States, 2019-2022.JAMA network open · 2024Article
- Drug supply measures and drug overdose mortality in the era of fentanyl and stimulants.Drug and alcohol dependence reports · 2023Article
- Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services.Drug and alcohol dependence · 2023Article
- Reducing the harms of xylazine: clinical approaches, research deficits, and public health context.Harm reduction journal · 2023Review
- Xylazine in Drug Seizure Reports and Overdose Deaths in the US, 2018-2022.medRxiv : the preprint server for health sciences · 2023Article
- Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.Harm reduction journal · 2023Article
- Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia.Harm reduction journal · 2023Article
- Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin.Harm reduction journal · 2022Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
2 authors.
Funding
Abstract
Tobias et al. (Am J Epidemiol. 2022;191 (2):241-247) present a novel analysis of time trends in fentanyl concentrations in the unregulated drug supply in British Columbia, Canada. The preexisting knowledge about unregulated drugs had come from law-enforcement seizures and postmortem toxicology. As both of these data sources are subject to selection bias, large-scale drug-checking programs are poised to be a crucial component of the public health response to the unrelenting increase in overdose in North America. As programs expand, we offer 2 guiding principles. First, the primary purpose of these programs is to deliver timely results to people who use drugs to mitigate health risks. Second, innovation is needed to go beyond criminal justice paradigms in laboratory analysis for a more nuanced understanding of health concerns. We provide examples of the role adulterants play in our understanding of drug harms. We also describe the applications and limitations of common laboratory assays, with implications for epidemiologic surveillance. While the research and direct service teams in British Columbia have taken groundbreaking steps, there is still a need to establish best practices for communicating results to sample donors in an approachable yet nonalarmist tone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.